Previous Close | 9.24 |
1-Year Change | 61.82% |
6-Months Change | 142.52% |
3-Months Change | 50% |
Moving Avg (50d) | 5.7716 |
Moving Avg (200d) | 5.1708 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.752B |
Beta (3-Years) | 1.89 |
Revenue Growth (ttm) | % |
Net Profit Margin (ttm) | 50.65% |
Return On Assets (ttm) | -32.73% |
EPS (ttm) | -0.65 |
PE Ratio (ttm) | -14.22 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |